| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |